PUXIN LTD-ADR (NEW)

US74704P4054 - ADR

1.36  +0.08 (+6.25%)

Fundamental Rating

1

NEW gets a fundamental rating of 1 out of 10. The analysis compared the fundamentals against 65 industry peers in the Diversified Consumer Services industry. NEW may be in some trouble as it scores bad on both profitability and health. NEW is valued expensive and it does not seem to be growing.



Quickly go to:

0

1. Profitability

1.1 Basic Checks

NEW had positive earnings in the past year.

1.2 Ratios

Industry RankSector Rank
ROA 1.02%
ROE 10.46%
ROIC N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

Industry RankSector Rank
OM -5.97%
PM (TTM) 1.73%
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A

More info and screens

0

2. Health

2.1 Basic Checks

NEW has more shares outstanding than it did 1 year ago.
Compared to 1 year ago, NEW has a worse debt to assets ratio.

2.2 Solvency

Based on the Altman-Z score of -0.29, we must say that NEW is in the distress zone and has some risk of bankruptcy.
A Debt/Equity ratio of 1.43 is on the high side and indicates that NEW has dependencies on debt financing.
Industry RankSector Rank
Debt/Equity 1.43
Debt/FCF N/A
Altman-Z -0.29
ROIC/WACCN/A
WACCN/A

2.3 Liquidity

NEW has a Current Ratio of 0.39. This is a bad value and indicates that NEW is not financially healthy enough and could expect problems in meeting its short term obligations.
NEW has a Quick Ratio of 0.39. This is a bad value and indicates that NEW is not financially healthy enough and could expect problems in meeting its short term obligations.
Industry RankSector Rank
Current Ratio 0.39
Quick Ratio 0.38

More info and screens

3

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 113.26% over the past year.
Looking at the last year, NEW shows a very negative growth in Revenue. The Revenue has decreased by -12.35% in the last year.
NEW shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 60.35% yearly.
EPS 1Y (TTM)113.26%
EPS 3YN/A
EPS 5YN/A
EPS growth Q2Q186.7%
Revenue 1Y (TTM)-12.35%
Revenue growth 3Y31.31%
Revenue growth 5Y60.35%
Revenue growth Q2Q-8.59%

3.2 Future

NEW is expected to show a decrease in Earnings Per Share. In the coming years, the EPS will decrease by -5.61% yearly.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y-91.96%
EPS Next 2Y-51.74%
EPS Next 3Y-29.84%
EPS Next 5Y-5.61%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

More info and screens

2

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 136.00 indicates a quite expensive valuation of NEW.
NEW is valuated expensively when we compare the Price/Earnings ratio to 24.55, which is the current average of the S&P500 Index.
NEW is valuated cheaply with a Price/Forward Earnings ratio of 1.50.
NEW's Price/Forward Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 20.92.
Industry RankSector Rank
PE 136
Fwd PE 1.5

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA -24.8

4.3 Compensation for Growth

NEW's earnings are expected to decrease with -29.84% in the coming years. This may justify a cheaper valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-51.74%
EPS Next 3Y-29.84%

More info and screens

0

5. Dividend

5.1 Amount

NEW does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

PUXIN LTD-ADR

NYSE:NEW (5/3/2022, 7:22:04 PM)

1.36

+0.08 (+6.25%)

Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupConsumer Services
GICS IndustryDiversified Consumer Services
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap118.95M
Analysts
Price Target
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
Industry RankSector Rank
PE 136
Fwd PE 1.5
P/S
P/FCF
P/OCF
P/B
P/tB
EV/EBITDA
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 1.02%
ROE 10.46%
ROCE
ROIC
ROICexc
ROICexgc
OM -5.97%
PM (TTM) 1.73%
GM N/A
FCFM
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover0.59
Health
Industry RankSector Rank
Debt/Equity 1.43
Debt/FCF
Debt/EBITDA
Cap/Depr
Cap/Sales
Interest Coverage
Cash Conversion
Profit Quality
Current Ratio 0.39
Quick Ratio 0.38
Altman-Z
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
Growth
EPS 1Y (TTM)113.26%
EPS 3YN/A
EPS 5Y
EPS growth Q2Q
EPS Next Y-91.96%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)-12.35%
Revenue growth 3Y31.31%
Revenue growth 5Y
Revenue growth Q2Q
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y